The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mr India, he’s not gonna tell me that. He’s told the market he know the issue and he has a plan to sort it . Give him a chance. I think the formats are a little high. It may initially go up high but settle 3-4 p once the news is lunched
Once clinical hold is lifted this will be worth 30 mill and north of 2.35 p I’m relaxed. When cbr news is issued this has ability to add 10 mill to the mix taking it to over 3p. As warren buffett says be brave when others are fearful and be fearful when others are brave. This is a buying op but I’m holding fire atm due to other commitments
Stu is a rude, ignorant idiot who gets a kick out of trying to put as shareholders down. Rather than being constructive about the company he enjoys trying to insult us. He makes a the odd few hundred quid here and there but I reckon he’s broke and a man of straw.
Vladik released this video as he must of been bombarded with emails from shareholders to offer some confidence. He believes in what he’s doing and so do I. The value of this business when clinical will get a re rate. CBR could be a game changer and make us shareholders some serious wealth.
Hi MrIndia can you private message me on this platform and I would be happy to share all the emails between vladik and me.
Hemo truth - im fully aware of what 1.3% represents. And what me and my colleagues own. If your trying to undermine my messages your entitled but these type of messages are exactly what puts me
Off messaging on these type of groups
This is now my largest holding and I wanted to offer some words that are real and genuine. I’m just as frustrated he ignored the other points I raised but I think they tried a director buying a few years ago and it did nothing. He is hoping that upon it being clinical institutional investors will pour in and then things really take off
A simple rights issue when this was 7p to say 5p would of got them all the money for half the shares (min). The globalco rns was the killer here which Vlad thought would be played down and not a big deal. I hope their is some big news coming (positive) but the old 9p is now approx 4.1. But: They have money in the bank which they did not have before and lets pray this money can add some serious value. I think this will get back to 3.5p plus in no time at all. This is def gonna be a double money from todays value.
Now this big bounce will be - clarification on globalco - vlad did make a hint (tweet) "big pharmacy is like EU, everything available but nothing gets done". Thats was one of frustration from their negociations and something big to announce in due course. perhaps use of their resources / staff and some funding for CDX. Next one is the start of clinical trials or the build up. This will settle at 3.5 - 4 and bounce between 3-5 in the interim.
My thoughts. I am 50% down btw and been averaging down all the way with avg of 3.3 ish now. would love to buy more but im balls deep already.
as soon as the arrangement is announced as per interview i think sentiment will change and buyers will return to absorb the mint conversion. The interview was very fast after the last rns re the globalco and i could sense panic from hemo management team to try and restore calm. I also think that vlad underestimated the market reaction to the globalco rns with the mint conversion to start straight after.
This company is far from dead but patience is key here. the market cap is less than money they hold in their bank atm thus valuing their product at 0. This will turn.
this company have approx 13 mil in the bank so they are trading at virtually cash value. if thats not enough to jump nothing will. cash value, assets and news imminent. the cln was 13 transfers at 900k plus one for the fees to set it up. there has been the fees plus 3 so 10 left to go, my count. looks like they do a transfer every 10 days or so. mint want this as low as poss so when they sell on market they profiteer.